Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis

Oncogene

Volumn 27, Issue 14, 2008, Pages 2055-2063

  Siddiqui, I A ^a   Malik, A ^a   Adhami, V M ^a   Asim, M ^a   Hafeez, B B ^a   Sarfaraz, S ^a   Mukhtar, H ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Angiogenesis; EGCG; Extrinsic pathway; Intrinsic pathway; Metastasis; TRAIL

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; EPIGALLOCATECHIN GALLATE; GELATINASE A; GELATINASE B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; STROMELYSIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL GROWTH; DISEASE ASSOCIATION; DRUG DOSE ESCALATION; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; TEA; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMELLIA SINENSIS; CARCINOMA; CATECHIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR MARKERS, BIOLOGICAL;

EID: 41149143243     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210840     Document Type: Article

References (33)

1. Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN et al. (2007). Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res 13: 1611-1619.
2. Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H. (2004). Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 64: 8715-8722.
3. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. (2006). Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle. Cancer Res 66: 1234-1240.
4. Bigelow RL, Cardelli JA. (2006). The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 25: 1922-1930.
5. Cantarella G, Risuglia N, Dell'eva R, Lempereur L, Albini A, Pennisi G et al. (2006). TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells. Br J Cancer 94: 1428-1435.
6. Chen X, Thakkar H, Tyan F, Gim S, Robinson H, Lee C et al. (2001). Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene 20: 6073-6083.
7. de Bock CE, Wang Y. (2004). Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer. Med Res Rev 24: 13-39.
8. Deeb D, Jiang H, Gao X, Hafner MS, Wong H, Divine G et al. (2004). Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-κB through suppression of IκBα phosphorylation. Mol Cancer Ther 3: 803-812.
9. Falschlehner C, Emmerich CH, Gerlach B, Walczak H. (2007). TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol 39: 1462-1475.
10. Gao S, Lee P, Wang H, Gerald W, Adler M, Zhang L et al. (2005). The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. Mol Endocrinol 19: 1792-1802.
11. He Q, Huang Y, Sheikh MS. (2004). Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells. Oncogene 23: 2554-2558.
12. He Q, Lee DI, Rong R, Yu M, Luo X, Klein M et al. (2002). Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway. Oncogene 21: 2623-2633.
13. Hu H, Jiang C, Schuster T, Li GX, Daniel PT, Lu J. (2006). Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway. Mol Cancer Ther 5: 1873-1882.
14. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. (2007). Cancer statistics, 2007. CA Cancer J Clin 57: 43-66.
15. Jian L, Xie LP, Lee AH, Binns CW. (2004). Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 108: 130-135.
16. Koshida K, Konaka H, Imao T, Egawa M, Mizokami A, Namiki M. (2004). Comparison of two in vivo models for prostate cancer: orthotopic and intratesticular inoculation of LNCaP or PC-3 cells. Int J Urol 11: 1114-1121.
17. Lakshmikanthan V, Kaddour-Djebbar I, Lewis RW, Kumar MV. (2006). SAHA-sensitized prostate cancer cells to TNFalpha-related apoptosis-inducing ligand (TRAIL): mechanisms leading to synergistic apoptosis. Int J Cancer 119: 221-228.
18. Lam WH, Kazi A, Kuhn DJ, Chow LM, Chan AS, Dou QP et al. (2004). A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]. Bioorg Med Chem 12: 5587-5593.
19. Landis-Piwowar KR, Kuhn DJ, Wan SB, Chen D, Chan TH, Dou QP. (2005). Evaluation of proteasome-inhibitory and apoptosis inducing potencies of novel (-)-EGCG analogs and their prodrugs. Int J Mol Med 15: 735-742.
20. Liston P, Fong WG, Korneluk RG. (2003). The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22: 8568-8580.
21. Munshi A, McDonnell TJ, Meyn RE. (2002). Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells. Cancer Chemother Pharmacol 50: 46-52.
22. Nencioni A, Wille L, Dal Bello G, Boy D, Cirmena G, Wesselborg S et al. (2005). Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells. Clin Cancer Res 11: 4259-4265.
23. Ozawa F, Friess H, Kleeff J, Xu ZW, Zimmermann A, Sheikh MS et al. (2001). Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer. Cancer Lett 163: 71-81.
24. Qin J, Xie LP, Zheng XY, Wang YB, Bai Y, Shen HF et al. (2007). A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun 354: 852-857.
25. Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N et al. (2006). S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA 103: 14825-14830.
26. Schimmer AD. (2004). Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 64: 7183-7190.
27. Siddiqui IA, Adhami VM, Afaq F, Ahmad N, Mukhtar H. (2004). Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem 91: 232-242.
28. Siddiqui IA, Adhami VM, Saleem M, Mukhtar H. (2006). Beneficial effects of tea and its polyphenols against prostate cancer. Mol Nutr Food Res 50: 130-143.
29. Siddiqui IA, Saleem M, Adhami VM, Asim M, Mukhtar H. (2007). Tea beverage in chemoprevention and chemotherapy of prostate cancer. Acta Pharmocol Sin 28: 1392-1408.
30. Stresemann C, Brueckner B, Musch T, Stopper H, Lyko F. (2006). Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res 66: 2794-2800.
31. Thurston G. (2003). Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 314: 61-68.
32. Yamaguchi K, Uzzo RG, Pimkina J, Makhov P, Golovine K, Crispen P et al. (2005). Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Oncogene 24: 5868-5877.
33. Zhang XD, Nguyen T, Thomas WD, Sanders JE, Hersey P. (2000). Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett 482: 193-199.